Federated Hermes’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Federated Hermes’s Portfolio ARIA Stock Details ARIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-51,144	Closed	-$636K	–	2255
2016 Q4	$636K	Buy	51,144 +10,400	+26%	+$125K	﹤0.01%	1251
2016 Q3	$558K	Buy	+40,744	New	+$409K	﹤0.01%	1254
2013 Q4	–	Sell	-3,465,401	Closed	-$63.8M	–	1824
2013 Q3	$63.8M	Sell	3,465,401 -103,422	-3%	-$2.01M	0.25%	85
2013 Q2	$62.4M	Buy	+3,568,823	New	+$63.3M	0.25%	85

Other funds holding ARIA

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Federated Hermes's ARIA Position: Q1 2017 in Review

Federated Hermes sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 51,144 shares — an estimated $636K sold.

Federated Hermes first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $63.8M in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

Federated Hermes reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
Federated Hermes sold 51,144 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $636K.
Federated Hermes first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
Federated Hermes's Ariad Pharmaceuticals Inc position peaked at $63.8M in Q3 2013.
1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Federated Hermes's 13F filing for Q1 2017, filed 12 May 2017.